Home › Trial NCT07494448
Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive Advanced Breast Cancer
- Trial IDNCT07494448
- StatusNot Yet Recruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorMedSIR
- Enrollment24
- Start date2026-07-01
- ConditionsHER 2 Positive Advanced Breast Cancer · Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.